Morning Market Gainers

shares climbed 104.39% to $2.33 after the company reported that it has regained compliance with the Nasdaq on $1 minimum bid price.

shares surged 27.42% to $1.58. Total revenue for the year climbed 308% to $5.3 million.

gained 12.49% to $18.46 after the company reported upbeat Q4 results.

shares jumped 12.41% to $52.70 after the company reported stronger-than-expected earnings for the fourth quarter.

shares surged 11.93% to $64.28 on better-than-expected Q4 results.

jumped 10.25% to $6.56. Evercore Partners upgraded Monster Worldwide from Hold to Buy and raised the price target from $6.50 to $8.50.

shares gained 9.95% to $4.20. On Wednesday, Cyan reported a Q4 loss of $0.15 per share on revenue of $30.5 million.

shares rose 7.33% to $2.93 after the company announced the acceptance of New Drug Application for cobimetinib in combination with vemurafenib for the treatment of patients with BRAF V600 mutation-positive advanced melanoma.

shares climbed 6.85% to $1,199.95 after the company reported stronger-than-expected results for the fourth quarter results.

jumped 5.61% to $135.61 after the company reported stronger-than-expected results for the fourth quarter.

shares rose 3.28% to $84.12 after the company reported better-than-expected earnings for the fourth quarter.

shares gained 2.66% to $47.54 after the company reported a narrower-than-expected Q4 loss.